HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jacques Rouanet Selected Research

N- (2- diethylaminoethyl)- 6- iodoquinoxaline- 2- carboxamide

4/2022Phase I study of [131I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol.
3/2021Efficacy of Targeted Radionuclide Therapy Using [131I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma.
10/2020Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapy.
11/2019Targeted Radionuclide Therapy Decreases Melanoma Lung Invasion by Modifying Epithelial-Mesenchymal Transition-Like Mechanisms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jacques Rouanet Research Topics

Disease

9Melanoma (Melanoma, Malignant)
10/2022 - 04/2019
5Neoplasms (Cancer)
04/2022 - 04/2019
1Lymphoma (Lymphomas)
01/2022
1Hematologic Diseases (Blood Diseases)
11/2021
1Lymphatic Metastasis
03/2021
1Extranodal Extension
03/2021
1Circulating Neoplastic Cells
11/2019
1Pityriasis Rubra Pilaris
01/2018

Drug/Important Bio-Agent (IBA)

5Radioisotopes (Radionuclides)IBA
04/2022 - 11/2019
4N- (2- diethylaminoethyl)- 6- iodoquinoxaline- 2- carboxamideIBA
04/2022 - 11/2019
4Melanins (Melanin)IBA
04/2022 - 11/2019
2benzamideIBA
04/2022 - 01/2021
2Immune Checkpoint InhibitorsIBA
01/2021 - 10/2020
1Bexarotene (LGD1069)FDA Link
01/2022
1AntibodiesIBA
11/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
03/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1LigandsIBA
10/2020
1Annexin A1IBA
05/2020
1pheomelaninIBA
04/2019
1AnionsIBA
04/2019
1eumelaninIBA
04/2019
1apremilastIBA
01/2018

Therapy/Procedure

7Therapeutics
04/2022 - 11/2019
2Immunotherapy
10/2022 - 10/2020
1Stem Cell Transplantation
11/2021